---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-187328"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2023-07-14T23:59:59+00:00"
generated_at: "2026-06-13T08:21:29.374929+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics appoints Dr. Fred Grossman as President and CMO; compensation terms disclosed

## Summary
- Base salary of $450,000/year; annual bonus target of 40% of base salary based on company/individual performance.
- Two option grants of 74,069 each (start date and Jan 2024) vesting over 3 years; additional equity possible.
- Severance: 9 months base salary plus 9 months accelerated vesting if terminated without cause or resigns for good reason.
- Employment effective July 17, 2023; initial term 2 years with auto-renewal.

## SEC filing metadata
- accession: 0001193125-23-187328
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2023-07-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/0001193125-23-187328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/d499175d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-187328
- JSON: https://secwatch.observer/filing/0001193125-23-187328.json
- Plain text: https://secwatch.observer/filing/0001193125-23-187328.txt

## Key facts
- Executive change
  Dr. Fred Grossman was appointed as President and Chief Medical Officer at Coya Therapeutics, Inc..
  - Action: appointed
  - Role: President and Chief Medical Officer
  source text: Dr. Fred Grossman, who will assume the role of President and Chief Medical Officer as of July 17, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835022/000119312523187328/0001193125-23-187328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.